Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis

Research output: Contribution to journalJournal articleResearchpeer-review

Background:Developmental arrest of fetal germ cells may lead to neoplastic transformation and formation of germ cell tumours via carcinoma in situ (CIS) cells. Normal fetal germ cell development requires complete erasure and re-establishment of DNA methylation. In contrast to normal spermatogonia, the genome of CIS cells remains unmethylated in the adult testis. We here investigated the possible active and passive pathways that can sustain the CIS genome hypomethylated in the adult testis.Methods:The levels of 5-methyl-cytosine (5mC) and 5-hydroxy-methyl-cytosine (5hmC) in DNA from micro-dissected CIS cells were assessed by quantitative measurements. The expression of TET1, TET2, APOBEC1, MBD4, APEX1, PARP1, DNMT1, DNMT3A, DNMT3B and DNMT3L in adult testis specimens with CIS and in human fetal testis was investigated by immunohistochemistry and immunofluorescence.Results:DNA from micro-dissected CIS cells contained very low levels of 5hmC produced by ten eleven translocation (TET) enzymes. CIS cells and fetal germ cells expressed the suggested initiator of active demethylation, APOBEC1, and the base excision repair proteins MBD4, APEX1 and PARP1, whereas TETs-the alternative initiators were absent. Both maintenance and de novo methyltransferases were detected in CIS cells.Conclusion:The data are consistent with the presence of an active DNA de-methylation pathway in CIS cells. The hypomethylated genome of CIS cells may contribute to phenotypic plasticity and invasive capabilities of this testicular cancer precursor.

Original languageEnglish
JournalBritish Journal of Cancer
Volume110
Issue number3
Pages (from-to)668-678
Number of pages11
ISSN0007-0920
DOIs
Publication statusPublished - 4 Feb 2014
Externally publishedYes

Bibliographical note

Funding Information:
The work herein was supported by the Research Fund of Rigshospitalet (to JEN, no. 9615.06.1.15), the Lundbeck Foundation (to ERM, no. R48-A4746) and The Danish Cancer Society (to ERM, no. R40-A2127-B1276). We are very grateful for the skilled technical work by Ana Ricci Nielsen, Brian Vendelbo Hansen and Betina F Nielsen. We thank Dr G Spagnoli for a generous gift of MAGE-A4 antibody, Dr K Okamoto for the generous gift of DNMT3L antibody, Dr PW Andrews for NTera2 cells, and Drs S Kitazawa and J Shipley for TCam-2 cells.

    Research areas

  • 5hmC, CIS, DNA demethylation, fetal germ cells

ID: 284205217